SCHEMBL28935768

SCHEMBL28935768

CC(C)(CO)Nc1ccc(C=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH5A1 P51649 1/20 0.43
▸ ABAT P80404 1/20 0.43
▸ ADRB2 P07550 1/20 0.39
▸ ADRB1 P08588 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ ALDH1A1 P00352 6/20 0.39
▸ CYP2A6 P11509 3/20 0.39
▸ EPHX2 P34913 1/20 0.39
▸ NR1H4 Q96RI1 1/20 0.39
▸ ALDH3A1 P30838 1/20 0.37
▸ ALDH1A3 P47895 1/20 0.37
▸ POLB P06746 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.35
▸ TYR P14679 1/20 0.35
▸ CYP2A13 Q16696 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ GRIA4 P48058 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14939968 0.83 ALDH1A1 (0.42) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL8674984 0.82 CYP2A6 (0.43) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL7284930 0.78 CYP2A6 (0.46) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL28935765 0.76 ALDH1A1 (0.40) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL26908497 0.76 CYP2A6 (0.48) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL1162021 0.74 NPSR1 (0.62) NPSR1ALDH1A1POLBHSD17B10
SCHEMBL13082375 0.74 L3MBTL1 (0.48) ADRB2ADRB1ADRB3ALDH1A1EPHX2
SCHEMBL25196222 0.73 CYP2A6 (0.41) ALDH5A1ABATADRB2ADRB1ADRB3
SCHEMBL31299182 0.73 ALDH1A1 (0.45) NPSR1ALDH1A1EPHX2NR1H4POLB
SCHEMBL24345747 0.73 NPSR1 (0.41) NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115583946-A Heterocyclic compounds and their use as CDK inhibitors 赛诺哈勃药业(成都)有限公司 2023-01-10 — — CN disclosed
Send feedback